2nd Annual Advances in Immuno-Oncology USA Congress

8 - 9 October 2019∣San Diego, USA

 

Oxford Global is proud to present our 2nd Annual Advances In Immuno-Oncology USA Congress, taking place on the 8 - 9 of October in San Diego, featuring over 40 presentations on the latest strategies and technologies impacting the Immuno-Oncology field. 

 

Our conference offers an extensive look across the development and discovery procedures in the Immuno-Oncology field. Day one will focus on the discovery process in Immuno-Oncology such as the key therapeutic strategies like CAR-T Cells therapies, and checkpoint inhibitors. The second stream is dedicated to biomarker development in translational research. Day two will concentrate on clinical aspects of Immuno-Oncology, Stream one focusing on screening techniques and animal models in preclinical development while strategies in trial design and challenges will be widely discussed in stream two.  

 

Key speakers include Executive Directors, Chief Executive Officers and Directors from leading pharma companies within the field such as Merck, Pfizer and Novartis. The conference is co-located with our 4th Annual Biomarkers and Precision Medicine USA Congress, which highlights the latest challenges and developments in clinical biomarkers and personalised medicine. The congresses offer scientific and business discussions with over 300 senior industry experts, ensuring valuable networking and interactive sessions.

 

View the agenda: https://bit.ly/2vrwiwW

 

For further information about the congress, please contact Guillaume Alonso at g.alonso@oxfordglobal.co.uk or visit the website https://bit.ly/2J9JJ6N